REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 174 filers reported holding REVANCE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $195,320 | -13.7% | 76,000 | +65.2% | 0.01% | -25.0% |
| Q1 2024 | $226,320 | -11.2% | 46,000 | +58.6% | 0.01% | -25.0% |
| Q4 2023 | $254,910 | -7.4% | 29,000 | +20.8% | 0.02% | -15.8% |
| Q3 2023 | $275,280 | -22.3% | 24,000 | +71.4% | 0.02% | -26.9% |
| Q2 2023 | $354,340 | – | 14,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
| Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
| ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
| Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
| Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
| Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
| EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
| PointState Capital LP | 438,200 | $11,568,000 | 0.13% |